Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has issued an update.
Piramal Pharma Limited has issued a corporate guarantee for its subsidiaries, Piramal Dutch Holdings N.V. and PPL Pharma Inc., to secure financing arrangements worth USD 216 million. This transaction, conducted on an arm’s length basis, is currently a contingent liability and has no immediate impact on the company’s financial status or stakeholder interests.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. It provides services and solutions to various sectors, including healthcare, research, and therapeutic areas, with a market focus on innovation and global reach.
YTD Price Performance: -6.29%
Average Trading Volume: 532,319
Current Market Cap: 320.7B INR
See more insights into PPLPHARMA stock on TipRanks’ Stock Analysis page.